| Ishwar Giri, MD | |
|
24 Hospital Ave, Danbury Hospital, Danbury, CT 06810 | |
| (203) 739-7000 | |
| Not Available |
| Full Name | Ishwar Giri |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538693775 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
Researchers at Oregon Health & Science University, University of Minnesota School of Public Health and George Mason University applaud Oregon's new birth control law which allows women age 18 or older to obtain some methods of hormonal contraception directly from pharmacies, without having to visit a prescribing clinician, yet note how the law could go even further to improve access to all forms of contraception, according to a viewpoint article published in the Journal of the American Medical Association today.
The liver, the largest internal organ, is the body's ultimate multitasker. While the liver is not glamorous or sentimental - there are no love songs about a broken liver - it simultaneously plays a key role in the body's metabolic, digestive and regulatory systems.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
Trevena, Inc. (NASDAQ:TRVN) today announced positive results from its Phase 1 trial of TRV734, which Trevena is developing with the goal of providing improved analgesia while avoiding gastrointestinal and respiratory side effects typically associated with opioids.
BAC, the leading provider of antibody-based affinity purification technologies, announces the launch of CaptureSelect HumanPlasma14 for highly specific, reproducible depletion of the 14 most abundant proteins from human blood plasma or serum. HumanPlasma14 is designed for single-step, single-use depletion of more than 99% of the abundant proteins.
› Verified 3 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Researchers at Oregon Health & Science University, University of Minnesota School of Public Health and George Mason University applaud Oregon's new birth control law which allows women age 18 or older to obtain some methods of hormonal contraception directly from pharmacies, without having to visit a prescribing clinician, yet note how the law could go even further to improve access to all forms of contraception, according to a viewpoint article published in the Journal of the American Medical Association today.
The liver, the largest internal organ, is the body's ultimate multitasker. While the liver is not glamorous or sentimental - there are no love songs about a broken liver - it simultaneously plays a key role in the body's metabolic, digestive and regulatory systems.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
Trevena, Inc. (NASDAQ:TRVN) today announced positive results from its Phase 1 trial of TRV734, which Trevena is developing with the goal of providing improved analgesia while avoiding gastrointestinal and respiratory side effects typically associated with opioids.
BAC, the leading provider of antibody-based affinity purification technologies, announces the launch of CaptureSelect HumanPlasma14 for highly specific, reproducible depletion of the 14 most abundant proteins from human blood plasma or serum. HumanPlasma14 is designed for single-step, single-use depletion of more than 99% of the abundant proteins.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ishwar Giri, MD 24 Hospital Ave, Danbury Hospital, Danbury, CT 06810 Ph: (203) 739-7000 | Ishwar Giri, MD 24 Hospital Ave, Danbury Hospital, Danbury, CT 06810 Ph: (203) 739-7000 |
News Archive
Researchers at Oregon Health & Science University, University of Minnesota School of Public Health and George Mason University applaud Oregon's new birth control law which allows women age 18 or older to obtain some methods of hormonal contraception directly from pharmacies, without having to visit a prescribing clinician, yet note how the law could go even further to improve access to all forms of contraception, according to a viewpoint article published in the Journal of the American Medical Association today.
The liver, the largest internal organ, is the body's ultimate multitasker. While the liver is not glamorous or sentimental - there are no love songs about a broken liver - it simultaneously plays a key role in the body's metabolic, digestive and regulatory systems.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
Trevena, Inc. (NASDAQ:TRVN) today announced positive results from its Phase 1 trial of TRV734, which Trevena is developing with the goal of providing improved analgesia while avoiding gastrointestinal and respiratory side effects typically associated with opioids.
BAC, the leading provider of antibody-based affinity purification technologies, announces the launch of CaptureSelect HumanPlasma14 for highly specific, reproducible depletion of the 14 most abundant proteins from human blood plasma or serum. HumanPlasma14 is designed for single-step, single-use depletion of more than 99% of the abundant proteins.
› Verified 3 days ago
Dr. Shivayogi V Magavi, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
Andrew Keller, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 27 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7155 | |
Mary E. Blackman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 79 Sand Pit Road, 102, Danbury, CT 06810 Phone: 203-749-5700 | |
Nirmalamma S Magavi, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
David D Weinshel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7173 | |
Dr. Michael Spiegel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 33 Germantown Rd, 1st Floor, Danbury, CT 06810 Phone: 203-794-5600 Fax: 203-794-5611 | |
Michael Cohenuram, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7742 Fax: 203-830-2090 |